Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment
Conditions
Non-Muscle Invasive Bladder Urothelial Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Chongqing Medica University, Chongqing, China
Study leads
Xin Gou, Professor
Study Chair
cymnk@163.com